Allison Pettit (@AllisonPettit2) profile picture

Biomedical scientist

Brisbane, Queensland
Joined August 2016
Photo by Allison Pettit (@AllisonPettit2)Photo by Allison Pettit (@AllisonPettit2)Photo by Allison Pettit (@AllisonPettit2)Photo by Allison Pettit (@AllisonPettit2)Photo by Allison Pettit (@AllisonPettit2)Photo by Allison Pettit (@AllisonPettit2)Photo by Allison Pettit (@AllisonPettit2)Photo by Allison Pettit (@AllisonPettit2)Photo by Allison Pettit (@AllisonPettit2)Photo by Allison Pettit (@AllisonPettit2)
Fantastic achievement toward addressing an unmet need in a vulnerable patient group. Congrats to the team.
TRI-based scientists Dr Kylie Alexander and Prof Jean-Pierre Levesque from @MaterResearch have solved a century-old mystery of why people with severe spinal cord and brain injuries develop debilitating bone growths around joints such as hips and shoulders. bit.ly/4gr7G94
1
2
86
Excited to be involved in this innovative multidisciplinary collaboration.
Australian researchers have received A$3.7M from the @ChanZuckerberg Initiative to use quantum light to transform deep tissue imaging in bone and bone marrow, and ultimately improve the diagnosis and management of conditions such as #osteoporosis and #cancer.
4
8
307
Allison Pettit retweeted
We’re excited to welcome new imaging grantees! 9 new Deep Tissue Imaging projects will drive development of imaging technology focused on obtaining cellular resolution readouts within complex living organisms. Learn about the projects czi.co/3uDKP7V
30
4
102
22,366
Here’s the breakdown of disciplines in the most junior scheme, Emerging Leader 1 (EL1). These are less than 5 years post-PhD or equivalent. 2/10
1
1
2
2,253
Next, the emerging leader 2 (EL2). These are 5-10 years post-PhD or equivalent. 3/10
1
1
2
2,213
The Leadership Level 1 (L1) are here. These are 10-15 years post-PhD or equivalent. A very disappointing year for L1 men, they received the lowest amount of funding. To be discussed later in this thread… 4/10
1
1
1
4
2,854
Finally, a summary of proportion of the total amount of funding awarded in each level since this scheme commenced in 2019. Assessing relative to opportunity, esp outputs vs $ inputs (not currently done) needs to be implemented to achieve equitable outcomes for all L1-3 ppl. 10/10
3
3
2
22
6,421
A summary of the numbers of applications (at left) vs awardees (at right) for each level for women is shown here from 2019 when this new scheme started. 9/10
1
1
4
2,181
In contrast, the Level 2 (L2) men were the biggest winners this year, particularly in Basic Science. L2 are 15-20 years post-PhD or equivalent. 5/10
1
1
5
2,610
I have analysed the 2023 NHMRC Investigator Grant data & summarise here. 3 ppl were funded in “other”, 2 at L3 and 1 at L2 ($8,422,029 total), I report here only those who ID’ed gender as man or woman. Total $ and # awarded in 2023 in each of 4 disciplines👇🏻 🧵 1/10
4
21
4
107
37,169
Last week's Mater Research Showcase was an opportunity to come together and reflect on the collective achievements of our researchers from the past year alongside the broader Mater community. Learn more: lnkd.in/gvW3QXee
3
3
316
Mater Research is highlighting the importance of breast cancer research and clinical trials this Breast Cancer Awareness Month. Learn about trial participant Monique's story: lnkd.in/gbmGtsHU
1
3
176
Mater Research is delighted to announce the winners of the 2023 Mater Publication of the Year Scheme. Congratulations to biomedical winner Dr Yuanhao Yang and clinical winner Dr Neisha D’Silva for their outstanding scholarly achievements!
1
1
5
880
Allison Pettit retweeted
🌎This World Osteoporosis Day, let’s break the silence on osteoporosis and emphasize the importance of early diagnosis, regular exercise, and balanced nutrition. Together, we can build a world where everyone has strong, healthy bones! #OsteoporosisAwareness
20
47
2,731
Allison Pettit retweeted
So honored to present #ANZBMS2023 and represent @ASBMR; great session all around with exciting macrophage data by @AllisonPettit2
#ANZBMS2023 We're excited to hear from the new @ASBMR president @lauracalvi3 about the role of #macrophages in 🦴 Followed by selected talks from @ANZBMSoc members including @AllisonPettit2 @KaraAnderson94 ‼️ Sessions are chaired by @AllisonPettit2 & Christian Girgis🎙️
5
25
1,138
A team of Mater Researchers are trialling a new Respiratory Syncytial Virus (RSV) vaccine at Mater Mothers' Hospital that could deliver single dose protection and reduce hospitalisation rates of premature babies after discharge. Learn more lnkd.in/geJWBBY4
2
1
2
337
A dedicated Mater clinic is helping to prevent stillbirth and other newborn complications for women who are pregnant with small babies, while also contributing valuable data to Mater Research studies and clinical trials. Learn more: lnkd.in/g4KAuydD
1
2
126
More children are getting Type 1 diabetes, and researchers, including Mater Researcher Professor Jo Forbes, are working to find out, “why?”. Learn more: lnkd.in/gjejyRgj
1
1
2
157
A landmark health study, the Indigenous @QLDFamilyCohort will roll out across Qld thanks to a $4.6m grant from the @nhmrc. The study, led by A/Prof @Kym_M_Rae will study the long-term wellbeing of 400 families from pregnancy until age five. Learn more: mater.li/landmark-health-stu…
3
2
17
551